Summary
Introduction
Cognitive-behavioral therapy (CBT) is the most researched and the best-supported treatment for binge eating disorder (BED) [1, 2] . Previous findings suggest that briefer, less costly interventions may be effective for at least a subset of patients with BED [2, 3] . Direct comparisons of brief and more intensive treatments seem warranted, given the apparent responsiveness of BED to a wide range of treatment modalities [4] . In addition, research regarding factors influencing treatment outcome in BED is needed to develop more effective treatments [5] [6] [7] [8] [9] . This way, patients suited for low-intensity treatments could be more easily identified [9] , thereby possibly improving the cost-effectiveness of treatment approaches for BED.
The aim of the present study was to compare the efficacy of a long-term and a short-term CBT treatment for individuals with BED. Both treatments have previously been evaluated with equivalent study designs and have proven to be efficacious for BED. Based on our previous findings of a marked reduction of binge eating within the first 8 weeks of the 16-session CBT [10] and the finding that the shortened intervention was efficacious for BED [11] , we wanted to test to what degree, if at all, the 16-week CBT outperformed the 8-week CBT with respect to BED-relevant outcomes.
A second goal of the present study was to examine potential moderators of treatment outcome. We aimed to examine whether i) rapid response to treatment [5, 7] and ii) high negative affect at pretreatment influenced the two CBT treatments differently.
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Participants and Methods

Participants
Participants were drawn from two different samples, both originating from studies conducted at the University of Basel, Switzerland. One sample (N = 40) included obese participants from a treatment trial evaluating the efficacy of a CBT program consisting of 16 sessions [12] that had been conducted during the period of 2001 to 2003 (referred to as CBT-L). The other sample (N = 36) was drawn from a study evaluating the efficacy of a short-term CBT with 8 sessions in a waitlist-controlled design [11] that had been conducted during the period of December 2004 to June 2007 (referred to as CBT-S). The CBT-S included participants from both the immediate treatment and the 8-week waitlist condition, as prior analyses had shown that there were no differences between those groups. Inclusion and exclusion criteria were identical for both samples (consider Munsch et al. [10] and Schlup et al. [11] for further information). Participant characteristics and comparisons of the two samples are shown in table 1.
Treatment Protocols
CBT-L
The efficacy of the CBT-L was demonstrated by Munsch et al. [10] . The protocol included 16 weekly 90-min group sessions in the active treatment phase and 5 booster sessions during the 12-month follow-up period. During these sessions, treatment contents discussed during the active treatment phase were revised, whereas no new treatment topics were introduced.
CBT-S
CBT-S is a shortened version of the CBT-L and has proven efficacy in a prior study [11] . There were 8 weekly 90-min group sessions in the active treatment phase, followed by 5 group sessions identical to the CBT-L during follow-up treatment. The protocol mainly focused on reducing the core symptomatology of BED. In contrast to the longer version, psychoeducation on balanced nutrition and modification of body concept were only marginally targeted (for the content of the two treatment protocols please consider Munsch et al. [10] and Schlup et al. [11] ).
Treatment groups in both samples started when 5-8 participants had been recruited. In both samples there were seven treatment groups carried through by fully qualified psychotherapists with specialized training in CBT and master's students of clinical psychology as co-therapists. Therapists and co-therapists in both studies were trained and supervised weekly by the senior researchers of the corresponding study (B.S. and S.M.).
Assessments and Procedures
Variables were assessed at pretreatment, at the end of treatment (i.e., following 16 weeks of CBT in the CBT-L sample and following 8 weeks of CBT in the CBT-S sample) and at 12-month follow-up. The number of self-reported binge episodes was assessed weekly during the active treatment phase (i.e., 8 times for the CBT-S and 16 times for the CBT-L) and at 3-, 6-, and 12-month follow-up.
Diagnostic Interviews
Screenings for current and lifetime mental disorders according to DSM-IV-TR in the German language were conducted at pretreatment and included structured diagnostic interviews for mental disorders on Axis I [13] and Axis II [14] .
Eating Disorder Psychopathology BED diagnosis relied on DSM-IV-TR research criteria for BED and was confirmed with the Eating Disorder Examination Interview (EDE) [15, 16] , a semi-structured interview with established reliability [17] and sensitivity to track changes in eating disorder psychopathology [16] . The EDE assesses features of BED, such as the number of objective binge episodes (OBEs) i.e. binge eating defined as consuming unusually large quantities of food with a subjective sense of loss of control, and abstainer rates ('remission'), i.e. proportion of patients not experiencing a binge during the last 28 days. In addition, the EDE comprises four subscales: dietary restraint, eating concern, weight concern and shape concern. Items are rated on a 7-point forced-choice scale (0-6), with higher scores reflecting greater severity or frequency of eating disorder psychopathology.
CBT-L (n = 40)
CBT-S (n = 36) Current and lifetime diagnoses according to DSM-IV-TR were assessed using structured clinical interviews for Axis I [13] and Axis II [14] disorders. Cognitive-Behavioral Short-and Long-Term Treatment for Binge Eating Disorder 263 i) Rapid response to treatment according to [7, 28] , defined on the basis of the weekly self-monitoring records of binge eating. According to the definition of rapid response used by other authors [5] , patients with a 65% or more decrease in binge eating within the first 4 weeks were considered rapid responders. We used linear mixed models to estimate the decrease in binge eating within the first 4 weeks as this allowed us to obtain estimates also for patients with missing values within that period. Rapid response was then used as a potential moderator of treatment outcome. ii) Mixed dietary-negative affect subtype, assessed according to the suggestions by [29] [30] [31] . The variable in our study was derived by cluster analysis from BDI, BAI and the EDE subscale dietary restraint. Participants' scores on these variables were submitted to a K-means cluster analysis using the Quick Cluster algorithm from SPSS 14. Outcomes were the number of objective binges as well as the four EDE subscales dietary restraint, eating concern, weight concern, and shape concern. The statistical models used were the same as for the comparison of the two treatments except that the moderator variable of interest was included here as a main effect and in all interaction terms.
Results
Dropouts
Dropout rates differed between the two samples, with significantly more dropouts in the CBT-L (14, or 35% of all participants) than in the CBT-S (5, or 14% of all participants) between baseline and 12-month follow-up (p = 0.034; c 2 test). In the CBT-L the majority of participants (12, or 30% of all participants) withdrew from treatment during the 16 weeks active treatment, in contrast to only one (2.8%) participant during the 8 weeks active treatment of CBT-S (p = 0.002). The reasons for dropouts included dissatisfaction with treatment (n = 6), lack of time (n = 2), major depression (n = 1) and other reasons (n = 3) in the CBT-L, and dissatisfaction (n = 1) in the CBT-S. During the 12-month follow-up period, there were no significant differences in the dropout rates between the two samples (2, or 5%, and 4, or 11% of all participants in the CBT-L and CBT-S, respectively; p = 0.32).
Compliance and Suitability
Participants attended on average 13.2 ± 2.2 (mean ± SE), or 82% of the 16 sessions in the CBT-L, and 6.6 ± 1.4, or 82% of the 8 sessions in the CBT-S. During the follow-up period of 5 booster sessions in both samples, participants in the CBT-L were present at 3.9 ± 1.5, or 78%, and participants in the CBT-S at 3.2 ± 1.3, or 65% of the sessions. No significant differences in compliance were found between the CBT-L and CBT-S samples (p = 0.95 for the active treatment phase, p = 0.074 for the follow-up phase; c 2 test). At the beginning and at the end of treatment, patients in the CBT-S gave significantly better ratings of suitability of treatment (-1.3; -1.7) than patients in the CBT-L (-0.4; -0.9; p < 0.05 for both tests), but not at the end of follow-up (-1.5 for CBT-L, -0.9 for CBT-S, p = 0.29).
For the number of self-reported binge episodes, participants filled out a record sheet monitoring the number of 'episodes of overeating during which you felt out of control' during the past week.
BMI
Weight and height were measured on a Seca electronic balance scale (Seca, Vogel and Halke, Hamburg, Germany) and by a stadiometer. BMI was calculated as weight in kilograms divided by the square of height in meters (kg/m 2 ).
Suitability of Treatment
Suitability of treatment was assessed with the session protocol of Graweet al. [18] . Participants rated item 19 ('I think another therapeutic procedure would be more suitable for me') on a 7-point Likert scale ranging from -3 (not at all) to +3 (yes, exactly). Ratings were assessed for each session during the active treatment phase and during follow-up.
Statistical Analyses
Comparison of the Two Treatments
Outcomes were remission from binge eating (based on EDE), number of OBEs (EDE), associated eating disorder psychopathology (four EDE subscales) and BMI.
The complete datasets of both samples were available for analysis, making it possible to compare the two intervention programs over the treatment course. To analyze continuously distributed outcome measures, we used linear mixed models [12, 19] . In studies where missing values frequently occur and if the absence only depends on observed and not on unobserved measurements (a so-called missing at random or MAR pattern sensu [20] ), linear mixed models have been shown to lead to more efficient and less biased results compared with complete case analyses or intent-to-treat analyses in which missing values have been imputed prior to the analysis using the last observation carried forward (LOCF) method. Also, results based on the LOCF method can be biased in either direction and thus can be interpreted as being conservative or liberal [21] . To analyze dichotomous outcome measures we applied a logistic-normal model representing a special case of a generalized linear mixed model (GLMM) in which the random effects structure is reduced to a random intercept only [22] . In cases where the predicted values of the dichotomous outcomes were close to 0 or 1, rendering the computation of estimates problematic, we used in addition Fisher's exact test to compare treatments at each measurement point. The statistical models contained the treatment (CBT-L vs. CBT-S) as a between-and time as a withinsubjects factors. Predicted mean outcome values based on the mixed model/GLMM were compared between the two treatments at the end of treatment and end of follow-up. Effect sizes according to Cohen [23] for continuous variables, or Odds ratios for dichotomous variables, were calculated at the end of treatment and at the end of follow-up. To indicate statistical significance, an alpha level of 0.05 was chosen, unless otherwise specified. Analyses were done using the software programs R 2.5 [24] and SPSS for Windows 14 (SPPS, Chicago, IL, USA). For generalized linear mixed models we used in addition the R packages lme4 [25] and glmmML [26] .
Moderator Analyses A significant pretreatment variable × treatment (here: short vs. long) interaction indicates that the pretreatment variable is a potential moderator [27] . We also tested for the interaction pretreatment variable × treatment × time to include the temporal aspect of the study but never obtained any significant result. Therefore, we here focus on the results based on the two-way interaction. Based on the literature, the following two pretreatment variables were included into the analyses:
ers had values for the EDE subscale dietary restraint that were on average much lower than those of the non-responders (1.47 vs. 2.06) in the CBT-L but almost identical in the CBT-S (1.88 for both responders and non-responders; interaction rapid response × sample, p = 0.047).
Mixed Dietary-Negative Affect Subtype
Cluster analyses with the BDI, the BAI and the EDE subscale dietary restraint (EDEres) revealed two different clusters. The majority of participants (72%) belonged to the high mixed dietary negative affect (mean values: BDI = 26.7 ± 8.1, BAI = 23.8 ± 9.3, EDEres = 2.31 ± 1.21), and 28% to the low mixed dietary negative affect subtype (mean values: BDI = 9.3 ± 5.6, BAI = 6.0 ± 4.5, EDEres = 2.06 ± 0.99). Percentages in the two clusters did not differ between the two treatments (c 2 = 0.89, p = 0.35). In the CBT-S subjects of the high mixed dietary negative affect subtype had higher values for the EDE subscale eating concern than those of low subtype (1.79 vs. 0.93), whereas the corresponding values in the CBT-L were quite similar (low subtype: 1.15, high subtype: 0.98; interaction subtype × sample, p = 0.021).
Discussion
This study examined a non-randomized direct comparison of a longer CBT comprising 16 sessions (CBT-L), with a shortened CBT consisting of 8 sessions (CBT-S). Both treatments were followed by booster sessions until 12-month follow-up. Overall, these findings underline the established efficacy of Table 2 provides the predicted means for all outcomes of the two treatments at baseline, end of treatment and end of follow-up.
Comparison of the Two Treatments
The percentage of remission was significantly higher for CBT-L than for CBT-S at the end of treatment, but not so at the end of follow-up (based on GLMM). In contrast, Fisher's exact test performed at separate measurement points and for the available cases only gave significantly higher values for CBT-L than for CBT-S at both end of treatment (p = 0.006) and end of follow-up (p = 0.007). Treatment means for OBEs and BMI were both very similar between CBT-S and CBT-L and did not significantly differ during treatment course. With respect to eating disorder pathology, CBT-S revealed slightly better results, but significant differences between CBT-S and CBT-L were only found for EDE shape concern at the end of treatment.
Moderator Analyses
Rapid Response 55% of all participants were classified as rapid responders. This percentage did not differ between the two treatments (c 2 = 0.61, p = 0.44). Averaged across the study period, rapid responders had lower values for OBEs in the CBT-S than non-responders (6.1 vs. 8.5), whereas in the CBT-L these two values were comparable (responders: 6.6, non-responders: 6.3; interaction rapid response × sample, p = 0.023). Also respond- disorder pathology could efficaciously be improved within a prolonged time span. The majority of the patients belonged to the mixed dietary negative affect subtype (72%). This moderator only influenced treatment success within CBT-S and only with respect to eating concern. Subjects of high negative subtype were the least successfully treated and hence should better be treated using a prolonged treatment option. However, as we did not find any further moderating effects for other outcomes, the interpretation of this result should also take into account the possibility of chance effects.
As limitations to the present study most importantly the nonrandomized design has to be addressed. Although the two studies were conducted in very comparable settings considering specific and nonspecific factors (e.g. patient characteristics, therapist effects), only a direct, randomized comparison of the two treatments within the same setting and patients sample and conducted by the same staff could minimize the effects of uncontrolled factors (e.g. different therapists, self-selection bias because patients knew about the length of treatment). Second, the statistical power was weak because of the rather small sample size; therefore, it is possible that we were unable to detect further meaningful differences between the two treatments. Third, inferences about between-group differences are limited by the fact that many missing values occurred, particularly with respect to data at the end of follow-up.
Bearing the before mentioned limitations in mind, our findings indicate that CBT, whether short-or long-term, was an effective treatment for the majority of patients. We have demonstrated that patients classified as non-rapid responders or those exhibiting high scores on the mixed dietary negative affect subtype benefit from prolonged treatment options with respect to eating disorder pathology. Future research should re-evaluate these preliminary findings thereby taking into account long-term outcome.
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The temporal course of binge eating in both treatments was characterized by marked improvements at the beginning of treatment that were maintained until the end of follow-up. Specific comparisons of treatment outcomes at different measurement points throughout the study suggest that the CBT-L produced better outcomes than the CBT-S, especially at the end of the active treatment phase, i.e. after 8 weeks of treatment for CBT-S and after 16 weeks of treatment for CBT-L. Results of the secondary analyses thus underlined the relative superiority of the CBT-L over the CBT-S at the end of treatment and, to a lesser extent, at the end of follow-up. An important issue in this respect, however, is the significantly higher dropout rate in the CBT-L (35%) compared to that in the CBT-S (14%). Since there were no statistically significant differences in baseline characteristics between the CBT-L and the CBT-S (e.g. age, age of onset of disorder, BMI, education level, or current or lifetime comorbidity rates), these factors are unlikely to influence the higher dropout rates in the CBT-L. It could be argued, however, that the dropouts may be related to the length of treatment itself, given that the reasons for dropout were dissatisfaction with treatment for six participants in CBT-L, compared to only one participant being dissatisfied with treatment in CBT-S. Slightly more than half of our study sample was classified as rapid responders. Treatment efficacy for OBEs was higher for rapid responders than non-rapid responders in CBT-S, whereas in CBT-L effects for both rapid and non-rapid responders were similar and also comparable to the effect of responders in the CBT-S. This suggests that within the shorter treatment option, patients' capacity to benefit from interventions early in treatment course is important, whereas in the CBT-L patients similarly profit from treatment until the 16th session, independent of the rapid response status. Longer treatment resulted in a better outcome in terms of EDE dietary restraint in rapid responders, whereas in CBT-S both rapid and non-rapid responders had almost identical values that were higher than those for rapid responders in CBT-L. It could therefore be hypothesized that core features of eating
